Showing 1 - 20 results of 2,555 for search '(((( b marked decrease ) OR ( a linear decrease ))) OR ( a latent decrease ))', query time: 0.49s Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7

    Table1_Leukocyte telomere length decreased the risk of mortality in patients with alcohol-associated liver disease.docx by Jiahong Yi (14481735)

    Published 2024
    “…Background<p>It is necessary to find latent indicators to predict the survival of alcohol-associated liver disease (ALD) patients. …”
  8. 8

    Posterior distribution of the effect of the latent variable on the probability of seeking traditional remedies after a potential dog bite indicates a decreased likelihood of individuals seeking traditional remedies. by Philip P. Mshelbwala (11278898)

    Published 2025
    “…<p>Posterior distribution of the effect of the latent variable on the probability of seeking traditional remedies after a potential dog bite indicates a decreased likelihood of individuals seeking traditional remedies.…”
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14

    Raw data of the charts in Fig 5. by Kam Pui Tam (19746865)

    Published 2024
    “…Concurrently, venetoclax inhibited Bcl-2 upregulated by either LMP-1 or EBNA-3C. Bort/venetoclax decreased the expression of phosphorylated p65 and Bcl-2 at serine 70 thereby suppressing the NF-κB signaling pathway and promoting apoptosis, respectively. …”
  15. 15

    Antibodies used in western blot analysis. by Kam Pui Tam (19746865)

    Published 2024
    “…Concurrently, venetoclax inhibited Bcl-2 upregulated by either LMP-1 or EBNA-3C. Bort/venetoclax decreased the expression of phosphorylated p65 and Bcl-2 at serine 70 thereby suppressing the NF-κB signaling pathway and promoting apoptosis, respectively. …”
  16. 16

    Raw data of the charts in Fig 3. by Kam Pui Tam (19746865)

    Published 2024
    “…Concurrently, venetoclax inhibited Bcl-2 upregulated by either LMP-1 or EBNA-3C. Bort/venetoclax decreased the expression of phosphorylated p65 and Bcl-2 at serine 70 thereby suppressing the NF-κB signaling pathway and promoting apoptosis, respectively. …”
  17. 17

    Raw data of the charts in Fig 1. by Kam Pui Tam (19746865)

    Published 2024
    “…Concurrently, venetoclax inhibited Bcl-2 upregulated by either LMP-1 or EBNA-3C. Bort/venetoclax decreased the expression of phosphorylated p65 and Bcl-2 at serine 70 thereby suppressing the NF-κB signaling pathway and promoting apoptosis, respectively. …”
  18. 18

    Raw data of the charts in Fig 6. by Kam Pui Tam (19746865)

    Published 2024
    “…Concurrently, venetoclax inhibited Bcl-2 upregulated by either LMP-1 or EBNA-3C. Bort/venetoclax decreased the expression of phosphorylated p65 and Bcl-2 at serine 70 thereby suppressing the NF-κB signaling pathway and promoting apoptosis, respectively. …”
  19. 19

    Raw data of the charts in Fig 2. by Kam Pui Tam (19746865)

    Published 2024
    “…Concurrently, venetoclax inhibited Bcl-2 upregulated by either LMP-1 or EBNA-3C. Bort/venetoclax decreased the expression of phosphorylated p65 and Bcl-2 at serine 70 thereby suppressing the NF-κB signaling pathway and promoting apoptosis, respectively. …”
  20. 20